Table of contents
June 2016 - Volume 21 - 3
Editorial
Perspective
- Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the ‘breakthrough’ (30 December, 2015)
Therapeutics/Prevention
Prognosis
- Cohort study: Fidgeting is associated with lower mortality risk (15 April, 2016)
Aetiology/Harm
Diagnosis
Prevalence
Letters
- Why doctors should convey the medical consensus on vaccine safety (21 April, 2016)
- Response to commentary by D Roth (20 April, 2016)